CPHI vs EXC · rev $4.1M vs P/E 17, rev $23.03B
China Pharma Holdings Inc (CPHI) versus Exelon Corporation (EXC) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported EXC revenue for 2024-12-31 was $23.03B. Net income was $2.46B. Revenue was up 6.0% from 2023-12-31 to 2024-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
CPHI currently screens at market cap $29.0M. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Not investment advice. Open the CPHI and EXC stock pages for the full models.
Not investment advice.